RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.270
-0.010 (-0.78%)
At close: Sep 15, 2025, 4:00 PM EDT
1.280
+0.010 (0.79%)
After-hours: Sep 15, 2025, 7:58 PM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $46.54 million as of September 15, 2025. Its market cap has increased by 102.11% in one year.
Market Cap
46.54M
Enterprise Value
35.04M
1-Year Change
102.11%
Ranking
Category
Stock Price
$1.27
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $46.54M, a decrease of -32.20%. That is a compound annual growth rate of -9.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 46.91M | 51.50% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |